Latest | F'cast | |
---|---|---|
Div Yield | 2.1% | 0.0% |
Div Cover | 1.3 | 2.6 |
Op Mrgn | 17.9% | 30.5% |
ROCE | 60.1% |
Latest | F'cast | |
---|---|---|
P/E | 36.5 | 16.7 |
PEG | 0.5 | 0.2 |
Pr/Revenue | 4.7 | 3.3 |
Pr/Book | 5.6 |
Latest | F'cast | |
---|---|---|
Revenue | 3.3% | -11.3% |
PBT | 175.8% | 80.0% |
EPS | 81.1% | 112.0% |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 24,384.00 | 1,548.00 | 103.00¢ | 92.0 | n/a | -39% | 280.00¢ | 3.0% |
31-Dec-20 | 26,617.00 | 3,916.00 | 244.00¢ | 37.4 | 0.3 | +137% | 280.00¢ | 3.1% |
31-Dec-21 | 37,417.00 | (265.00) | 8.00¢ | 1,350.8 | n/a | -97% | 287.00¢ | 2.7% |
31-Dec-22 | 44,351.00 | 2,501.00 | 212.00¢ | 65.9 | 0.0 | +2,550% | 290.00¢ | 2.1% |
31-Dec-23 | 45,811.00 | 6,899.00 | 384.00¢ | 34.4 | 0.4 | +81% | 290.00¢ | 2.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 50,627.27 | 15,463.31 | 657.61p | 17.1 | 0.2 | +112% | 252.44p | 0.0% |
31-Dec-25 | 54,298.16 | 17,530.25 | 747.51p | 15.1 | 1.1 | +14% | 264.54p | 0.0% |
31-Dec-26 | 56,979.77 | 19,331.02 | 809.16p | 13.9 | 1.7 | +8% | 275.46p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Result of AGM | 11-Apr-2024 | 17:30 | RNS |
AstraZeneca increases 2024 dividend by 7% | 11-Apr-2024 | 07:00 | RNS |
Enhertu approved in US for HER2+ solid tumours | 08-Apr-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 11,268.00p |
Change Today | 18.00p |
% Change | 0.16 % |
52 Week High | 12,294.00 |
52 Week Low | 9,501.00 |
Volume | 3,186,127 |
Shares Issued | 1,550.22m |
Market Cap | £174,679m |
RiskGrade | 123 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 8 |
Buy | 13 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 1 |
Total | 28 |
Latest | Previous | |
---|---|---|
2nd Interim | 1st Interim | |
Ex-Div | 22-Feb-24 | 10-Aug-23 |
Paid | 25-Mar-24 | 11-Sep-23 |
Amount | 197.00¢ | 93.00¢ |
Time | Volume / Share Price |
17:33 | 14,272 @ 11,266.78p |
17:08 | 2,118 @ 11,257.91p |
17:07 | 4,644 @ 11,252.97p |
17:06 | 990 @ 11,231.83p |
16:38 | 3,600 @ 11,268.00p |
You are here: research